LI
MRNA icon

Louisbourg Investments’s Moderna MRNA Stock Holding History

Louisbourg Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-62
Closed -$1.83K – 222
2025
Q4 		$1.83K Hold
62
– – ﹤0.01% 195
2025
Q3 		$1.6K Hold
62
– – ﹤0.01% 191
2025
Q2 		$1.71K Hold
62
– – ﹤0.01% 185
2025
Q1 		$1.76K Hold
62
– – ﹤0.01% 165
2024
Q4 		$2.58K Hold
62
– – ﹤0.01% 154
2024
Q3 		$4.14K Buy
62
+40
+182% +$3.67K ﹤0.01% 158
2024
Q2 		$2.61K Hold
22
– – ﹤0.01% 155
2024
Q1 		$2.34K Sell
22
-21
-49% -$2.12K ﹤0.01% 154
2023
Q4 		$4.28K Buy
+43
New +$3.62K ﹤0.01% 151

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Louisbourg Investments's MRNA Position: Q1 2026 in Review

Louisbourg Investments sold out of Moderna (MRNA) in Q1 2026, closing a stake of 62 shares — an estimated $1.83K sold.

Louisbourg Investments first reported a position in MRNA in Q4 2023 and held it in 9 quarters. The position peaked at $4.28K in Q4 2023. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Louisbourg Investments reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Louisbourg Investments sold 62 Moderna shares in Q1 2026, an estimated $1.83K.
  • Louisbourg Investments first reported a position in Moderna in Q4 2023 and held it in 9 quarters.
  • Louisbourg Investments's Moderna position peaked at $4.28K in Q4 2023.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Louisbourg Investments's 13F filing for Q1 2026, filed 22 Apr 2026.